好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Amyotrophic Lateral Sclerosis Survival and Occupational Lead Exposure in the Danish National Patient Registry
General Neurology
P2 - Poster Session 2 (11:45 AM-12:45 PM)
15-002

We investigated the relationship between occupational lead (Pb) exposure and ALS survival using the Danish registry.

Risk factors associated with amyotrophic lateral sclerosis (ALS) survival are not well understood. Lead is a known neurotoxicant, but only few studies have examined its effect on ALS survival.

We identified 2,161 ALS cases diagnosed between 1982-2013 with full employment history, and at least two ALS diagnoses, one of them being in an inpatient setting. Cases were followed until March 1, 2017, or until censored. We examined Pb exposure as ever/never exposed to a Pb-job, and to a Pb-job by probability, based on a Danish job-exposure matrix. Pb exposure was also evaluated in 5 and 10-year lags. We evaluated survival using Cox proportional hazard models, adjusted for age, socioeconomic status, marital status, and diagnosis year, and stratified by sex and age of diagnosis.

Median survival and age at diagnosis of ALS cases was 16.8 months and 63.5 years, respectively. Survival was worse for women ever exposed to Pb with a high probability (no lag hazard ratio (HR): 1.17, 95%CI: 0.92, 1.48) compared to non-exposed women, and this was similar with either a 5 or 10 year lag period. Hazards ratios (HR) were slightly negative for high probability Pb-exposed men diagnosed at age 60-69 (lag 5 HR: 0.66, 95%CI: 0.45, 0.98), but reversed for men diagnosed at age 70 and later (lag 5 HR: 2.03, 95%CI: 1.13, 3.64).

Occupational lead exposure contributed to shorter survival among women with occupational Pb exposure, and differences in survival by age of diagnosis among men. Our study adds to three others, one of which observed higher HRs among women. The lagged analysis results could suggest some healthy-worker effect or that earlier lead exposures before ALS onset are more relevant for survival. Supported by T32ES007069, P30ES000002, and R01ES019188.

Authors/Disclosures
Ian Tang, PhD (Harvard TH Chan School of Public Health)
PRESENTER
Dr. Tang has received research support from NIH.
Aisha S. Dickerson, PhD (Harvard T.H. School of Public Health) No disclosure on file
Johnni Hansen, PhD (Danish Cancer Society Research Center) Dr. Hansen has nothing to disclose.
Marc Weisskopf, PhD (Harvard TH Chan School of Public Health) Prof. Weisskopf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kaiser Permanente Research Biobank. The institution of Prof. Weisskopf has received research support from ALS Network. The institution of Prof. Weisskopf has received research support from NIH. The institution of Prof. Weisskopf has received research support from Paralyzed Veterans of America. The institution of Prof. Weisskopf has received research support from CDC/ATSDR. The institution of Prof. Weisskopf has received research support from JPB Foundation.